Search

Oxaliplatin extravasation management

"Oxaliplatin has both irritant and vesicant properties that are difficult to distinguish at initial clinical presentation" Van Praet et al (2022).

"Oxaliplatin has both irritant and vesicant properties that are difficult to distinguish at initial clinical presentation" Van Praet et al (2022).

ReTweet

Oxaliplatin extravasation management

Abstract:

This case report describes a unique case of chronic reaction after extravasation of oxaliplatin. The pain and extensive subcutaneous induration did not resolve after 9 months of conservative treatment. Surgical debridement with removal of the totally implantable venous access device (TIVAD) resulted in immediate resolution of the symptoms. Oxaliplatin has both irritant and vesicant properties that are difficult to distinguish at initial clinical presentation. In most literature cases complaints resolve within 3 months with conservative treatment yet surgical debridement should be considered if complaints persist beyond this period.


Reference:

Van Praet L, Boecxstaens V, Douchy T. Surgical management after Oxaliplatin extravasation: A case report and literature review. J Vasc Access. 2022 Feb 8:11297298221075237. doi: 10.1177/11297298221075237. Epub ahead of print. PMID: 35130786.

Facebook Twitter Linkedin Rss Envelope

About IVTEAM citation library

IVTEAM has established itself as a core global resource for infusion and vascular access practitioners. Each day 6K users have access thousands of pages of easy to access relevant intravenous news and updates. IVTEAM offers its visitors a premier service that has no financial or subscriber based restrictions. The editorial stance of IVTEAM is to ensure no editorial restrictions exist; content remains unbiased and independent.

It is crucial that IVTEAM stays up-to-date and offers visitors regular, current updates. Each day news feeds are analysed, websites searched and various additional sources of information visited. This results in large amounts of data being sifted through for relevant information every day. Only a small amount of data is relevant to IV practice and makes it onto IVTEAM.

Read more
Copyright 2025 © IVTEAM. All rights Reserved.

Register for free citation alerts

Supporting your vascular access and infusion therapy learning journey